Trial ID BGB-11417-105 | Maryland Oncology Hematology Trial ID BGB-11417-105 – Maryland Oncology Hematology

Trial ID BGB-11417-105

Trial Information - Phase Ib/II

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 asMonotherapy, in Combination With Dexamethasone andCarfilzomib/Dexamethasone in Patients WithRelapsed/Refractory Multiple Myeloma and t(11;14)

Protocol ID: BGB-11417-105

Sponsor: BeiGene USA Inc.

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Multiple Myeloma

Investigator

Mohit Narang, MD

Sponsor

BeiGene USA Inc.
« Clinical Trails Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology